Chiral cysteine-copper ion-based assemblies for improved phototherapy

J Colloid Interface Sci. 2024 Mar:657:993-1002. doi: 10.1016/j.jcis.2023.11.170. Epub 2023 Dec 1.

Abstract

Phototherapy, encompassing photothermal therapy and photodynamic therapy, is gaining attention as an appealing cancer treatment modality. To enhance its clinical implementation, a comprehensive exploration of the pivotal factors influencing phototherapy is warranted. In this study, the L/d-cysteine (Cys)-copper ion (Cu2+) chiral nanoparticles, through the assembly of L/d-Cys-Cu2+ coordination complexes, were constructed. We found that these nanoparticles interacted with chiral liposomes in a chirality-dependent manner, with d-Cys-Cu2+ nanoparticles exhibiting more than three times stronger binding affinity than l-Cys-Cu2+ nanoparticles. Furthermore, we demonstrated that the d-Cys-Cu2+ nanoparticles were more efficiently internalized by Hela cells in contrast with l-Cys-Cu2+. On this basis, indocyanine green (ICG), acting as both photothermal and photodynamic agent, was encapsulated into L/d-Cys-Cu2+ nanoparticles. Experimental results showed that the l-Cys-Cu2+-ICG and d-Cys-Cu2+-ICG nanoparticles displayed almost identical photothermal performance and singlet oxygen (1O2) generation capability in aqueous solution. However, upon laser irradiation, the d-Cys-Cu2+-ICG nanoparticles achieved enhanced anti-tumor effects compared to l-Cys-Cu2+-ICG due to their chirality-promoted higher cellular uptake efficiency. These findings highlight the crucial role of chirality in phototherapy and provide new perspectives for engineering cancer therapeutic agents.

Keywords: Antitumor; Cellular uptake; Chirality; Cysteine; Phototherapy.

MeSH terms

  • Cell Line, Tumor
  • Copper / pharmacology
  • Cysteine
  • HeLa Cells
  • Humans
  • Indocyanine Green / chemistry
  • Nanoparticles* / chemistry
  • Photochemotherapy*
  • Phototherapy / methods

Substances

  • Copper
  • Cysteine
  • Indocyanine Green